Business Description
Tiziana Life Sciences is a UK-based biotech firm focused on creating new treatments for conditions affecting the brain, lungs, and immune system. Its most advanced drug, Foralumab, targets a protein on immune cells and is being studied as a potential treatment for a range of serious conditions, including multiple sclerosis, Crohn's disease, and rheumatoid arthritis. The company is also working on a second drug designed to block a key driver of inflammation, with potential uses in both autoimmune and cancer care.
